Ultra-Low Dose Thoracic CT Derived Morphomics in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Annals of the American Thoracic Society
DOIs	https://doi.org/10.1513/annalsats.202411-1151oc
Publication status	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{145cb0aeacf248c19e1cf1a56935427f,

title = "Ultra-Low Dose Thoracic CT Derived Morphomics in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor",

keywords = "Ivacaftor, Medicine, Cystic fibrosis, Radiology, Internal medicine, Cystic fibrosis transmembrane conductance regulator",

author = "David Ryan",

year = "2025",

doi = "10.1513/annalsats.202411-1151oc",

language = "English",

journal = "Annals of the American Thoracic Society",

issn = "2329-6933",

publisher = "American Thoracic Society",

}

TY - JOUR

T1 - Ultra-Low Dose Thoracic CT Derived Morphomics in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor

AU - Ryan, David

PY - 2025

Y1 - 2025

KW - Ivacaftor

KW - Medicine

KW - Cystic fibrosis

KW - Radiology

KW - Internal medicine

KW - Cystic fibrosis transmembrane conductance regulator

U2 - 10.1513/annalsats.202411-1151oc

DO - 10.1513/annalsats.202411-1151oc

M3 - Article

SN - 2329-6933

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

ER -